These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 18419471)
21. Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide™ Pet Gel A or aluminum hydroxide adjuvants in mice. Portuondo DL; Batista-Duharte A; Ferreira LS; de Andrade CR; Quinello C; Téllez-Martínez D; de Aguiar Loesch ML; Carlos IZ Vaccine; 2017 Aug; 35(34):4430-4436. PubMed ID: 28687406 [TBL] [Abstract][Full Text] [Related]
22. Immunoprotection against systemic candidiasis in mice. Tavares D; Ferreira P; Vilanova M; Videira A; Arala-Chaves M Int Immunol; 1995 May; 7(5):785-96. PubMed ID: 7547705 [TBL] [Abstract][Full Text] [Related]
23. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis. Han Y; Rhew KY Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645 [TBL] [Abstract][Full Text] [Related]
24. Vaccination with Secreted Aspartyl Proteinase 2 Protein from Shukla M; Rohatgi S Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125 [TBL] [Abstract][Full Text] [Related]
26. Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine. Chawla B; Mahajan B; Oakley M; Majam VF; Belmonte A; Sedegah M; Shimp RL; Kaslow DC; Kumar S Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308085 [TBL] [Abstract][Full Text] [Related]
27. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis. Xin H; Glee P; Adams A; Mohiuddin F; Eberle K Vaccine; 2019 Apr; 37(18):2430-2438. PubMed ID: 30930005 [TBL] [Abstract][Full Text] [Related]
28. An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response. Hu XD; Chen ST; Li JY; Yu DH; Yi-Zhang ; Cai H Vaccine; 2010 Mar; 28(12):2408-15. PubMed ID: 20064480 [TBL] [Abstract][Full Text] [Related]
29. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis. Xin H Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842 [TBL] [Abstract][Full Text] [Related]
30. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice. Fierer J; Waters C; Walls L J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371 [TBL] [Abstract][Full Text] [Related]
31. Plasma beads loaded with Candida albicans cytosolic proteins impart protection against the fungal infection in BALB/c mice. Ahmad E; Fatima MT; Saleemuddin M; Owais M Vaccine; 2012 Nov; 30(48):6851-8. PubMed ID: 23044405 [TBL] [Abstract][Full Text] [Related]
32. Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors. Santoni G; Boccanera M; Adriani D; Lucciarini R; Amantini C; Morrone S; Cassone A; De Bernardis F Infect Immun; 2002 Sep; 70(9):4791-7. PubMed ID: 12183521 [TBL] [Abstract][Full Text] [Related]
33. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy. Jackson RJ; Worley M; Trivedi S; Ranasinghe C Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host. Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Klinman D; Berzofsky JA J Immunol; 2006 Nov; 177(9):6336-43. PubMed ID: 17056564 [TBL] [Abstract][Full Text] [Related]
35. Protective effect of fungal extracellular vesicles against murine candidiasis. Vargas G; Honorato L; Guimarães AJ; Rodrigues ML; Reis FCG; Vale AM; Ray A; Nosanchuk JD; Nimrichter L Cell Microbiol; 2020 Oct; 22(10):e13238. PubMed ID: 32558196 [TBL] [Abstract][Full Text] [Related]
36. Adjuvant effect of polysaccharide from fruits of Physalis alkekengi L. in DNA vaccine against systemic candidiasis. Yang H; Han S; Zhao D; Wang G Carbohydr Polym; 2014 Aug; 109():77-84. PubMed ID: 24815404 [TBL] [Abstract][Full Text] [Related]
37. Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis. Raska M; Beláková J; Wudattu NK; Kafková L; Růzicková K; Sebestová M; Kolár Z; Weigl E Folia Microbiol (Praha); 2005; 50(1):77-82. PubMed ID: 15954537 [TBL] [Abstract][Full Text] [Related]
38. Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. Romani L; Mencacci A; Cenci E; Mosci P; Vitellozzi G; Grohmann U; Puccetti P; Bistoni F J Infect Dis; 1992 Dec; 166(6):1384-92. PubMed ID: 1358988 [TBL] [Abstract][Full Text] [Related]
39. Vaccine potential of plasma bead-based dual antigen delivery system against experimental murine candidiasis. Ahmad E; Zia Q; Fatima MT; Owais M; Saleemuddin M Int J Biol Macromol; 2015 Nov; 81():100-11. PubMed ID: 26231333 [TBL] [Abstract][Full Text] [Related]
40. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]